دورية أكاديمية

Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma

التفاصيل البيبلوغرافية
العنوان: Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma
المؤلفون: Clemens, Mark W., Medeiros, L. Jeffrey, Butler, Charles E., Hunt, Kelly K., Fanale, Michelle A., Horwitz, Steven, Weisenburger, Dennis D., Liu, Jun, Morgan, Elizabeth A., Kanagal Shamanna, Rashmi, Parkash, Vinita, Ning, Jing, Sohani, Aliyah R., Ferry, Judith A., Mehta Shah, Neha, Dogan, Ahmed, Liu, Hui, Thormann, Nora, DI NAPOLI, Arianna, Lade, Stephen, Piccolini, Jorge, Reyes, Ruben, Williams, Travis, Mccarthy, Colleen M., Hanson, Summer E., Nastoupil, Loretta J., Gaur, Rakesh, Oki, Yasuhiro, Young, Ken H., Miranda, Roberto N.
المساهمون: Clemens, Mark W., Medeiros, L. Jeffrey, Butler, Charles E., Hunt, Kelly K., Fanale, Michelle A., Horwitz, Steven, Weisenburger, Dennis D., Liu, Jun, Morgan, Elizabeth A., Kanagal Shamanna, Rashmi, Parkash, Vinita, Ning, Jing, Sohani, Aliyah R., Ferry, Judith A., Mehta Shah, Neha, Dogan, Ahmed, Liu, Hui, Thormann, Nora, DI NAPOLI, Arianna, Lade, Stephen, Piccolini, Jorge, Reyes, Ruben, Williams, Travi, Mccarthy, Colleen M., Hanson, Summer E., Nastoupil, Loretta J., Gaur, Rakesh, Oki, Yasuhiro, Young, Ken H., Miranda, Roberto N.
بيانات النشر: American Society of Clinical Oncology
سنة النشر: 2016
المجموعة: Sapienza Università di Roma: CINECA IRIS
مصطلحات موضوعية: adult, aged, 80 and over, breast implant, breast neoplasm, chemotherapy, adjuvant, disease management, disease-free survival, female, follow-up studie, human, kaplan-meier estimate, lymphoma, large-cell, anaplastic, middle aged, radiotherapy, retrospective studie, treatment outcome, cancer research, oncology
الوصف: Breast implant-associated anaplastic large-cell lymphoma (BI-ALCL) is a rare type of T-cell lymphoma that arises around breast implants. The optimal management of this disease has not been established. The goal of this study is to evaluate the efficacy of different therapies used in patients with BI-ALCL to determine an optimal treatment approach.In this study, we applied strict criteria to pathologic findings, assessed therapies used, and conducted a clinical follow-up of 87 patients with BI-ALCL, including 50 previously reported in the literature and 37 unreported. A Prentice, Williams, and Peterson model was used to assess the rate of events for each therapeutic intervention.The median and mean follow-up times were 45 and 30 months, respectively (range, 3 to 217 months). The median overall survival (OS) time after diagnosis of BI-ALCL was 13 years, and the OS rate was 93% and 89% at 3 and 5 years, respectively. Patients with lymphoma confined by the fibrous capsule surrounding the implant had better event-free survival (EFS) and OS than did patients with lymphoma that had spread beyond the capsule (P = .03). Patients who underwent a complete surgical excision that consisted of total capsulectomy with breast implant removal had better OS (P = .022) and EFS (P = .014) than did patients who received partial capsulectomy, systemic chemotherapy, or radiation therapy.Surgical management with complete surgical excision is essential to achieve optimal EFS in patients with BI-ALCL.
نوع الوثيقة: article in journal/newspaper
اللغة: English
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/26628470; info:eu-repo/semantics/altIdentifier/wos/WOS:000374327000013; volume:34; issue:2; firstpage:160; lastpage:168; numberofpages:9; journal:JOURNAL OF CLINICAL ONCOLOGY; http://hdl.handle.net/11573/869092Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84954210377; http://jco.ascopubs.org/content/34/2/160.full.pdf+htmlTest
DOI: 10.1200/JCO.2015.63.3412
الإتاحة: https://doi.org/10.1200/JCO.2015.63.3412Test
http://hdl.handle.net/11573/869092Test
http://jco.ascopubs.org/content/34/2/160.full.pdf+htmlTest
حقوق: info:eu-repo/semantics/closedAccess
رقم الانضمام: edsbas.BEDDC62D
قاعدة البيانات: BASE